X0306 4 2021-01-04 false 0001597553 Sage Therapeutics, Inc. SAGE 0001291963 Greene Barry E C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true true false false President and CEO Stock Options (Right to buy) 85.82 2021-01-04 4 A false 390000.00 0.00 A 2031-01-04 Common Stock 390000.00 390000.00 D The securities awarded on January 4, 2021 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 97,500 shares of common stock shall vest on the one year anniversary of January 4, 2021, with 292,500 shares vesting in 36 equal monthly installments thereafter, so long as the Reporting Person remains an employee or consultant of the Company on each of the applicable vesting dates. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Barry Greene 2021-01-06